(Q43685539)

English

Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study

scientific article published in May 2000

Statements

Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study (English)
192-196

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit